|
IMGN
|
ImmunoGen, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
BLU
|
BELLUS Health Inc.
|
0.09%
|
CA
|
TSX
|
|
KURA
|
Kura Oncology, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
SMMT
|
Summit Therapeutics plc
|
0.07%
|
US
|
NASDAQ
|
|
SANA
|
Sana Biotechnology, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
0.07%
|
US
|
NASDAQ
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
LYEL
|
Lyell Immunopharma, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
FDMT
|
4D Molecular Therapeutics, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
0.07%
|
US
|
NASDAQ
|